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Abstract
Juxtaglomerular cell tumor (JGCT) generally affects adolescents and young adults. The patients experience
symptoms related to hypertension and hypokalemia due to renin-secretion by the tumor. Grossly, the tumor is well
circumscribed with fibrous capsule and the cut surface shows yellow or gray-tan color with frequent hemorrhage.
Histologically, the tumor is composed of monotonous polygonal cells with entrapped normal tubules.
Immunohistochemically, tumor cells exhibit a positive reactivity for renin, vimentin and CD34. Ultrastructurally,
neoplastic cells contain rhomboid-shaped renin protogranules. Genetically, losses of chromosomes 9 and 11 were
frequently observed. Clinically, the majority of tumors showed a benign course, but rare tumors with vascular
invasion or metastasis were reported. JGCT is a curable cause of hypertensive disease if it is discovered early and
surgically removed, but may cause a fatal outcome usually by a cerebrovascular attack or may cause fetal demise
in pregnancy. Additionally, pathologists and urologists need to recognize that this neoplasm in most cases pursues
a benign course, but aggressive forms may develop in some cases.
Introduction
Juxtaglomerular cell tumor (JGCT) is a very rare cause of
hypertension that was first described by Robertson et al.
in 1967 and the name was coined by Kihara in 1968 [1,2].
To date, approximately 100 cases with JGCT have been
reported. Clinically, this tumor is characterized by hyper-
tension, hyperaldosteronism and hypokalemia secondary
to excessive renin secretion by tumor cells [3-8]. In this
article, we introduce the general overview of JGCT with
focus on pathobiological aspects.
Epidemiology
This tumor affects adolescents and young adults, with
peak prevalence in the second and third decades of life
with a female predominance [8-10]. Haab et al. (1995)
detected eight JGCTs among 30,000 patients at a hyper-
tensive clinic [11].
Clinical findings
Patients with JGCT present with various symptoms
including headaches, retinopathy, double vision, dizziness,
nausea, vomiting, polyuria and proteinuria [8,12]. Most of
these symptoms may be attributed to hypertension or
hypokalemia. Clinically, JGCT is subdivided into three
categories [13]. The typical variant, which accounts for the
majority of JGCT, has characteristically high renin concen-
tration, hyperaldosteronism, hypokalemia and hyperten-
sion [4,5]. Second most common presentation is the
atypical variant showing hypertension with normal potas-
sium level [8]. The third, non-functioning variant is very
rare and is characterized by a normal blood pressure and
normal potassium level [14-16]. Clinicians should strongly
suspect JGCT if they encounter adolescent or young adult
patients with severe or even moderate hypertension asso-
ciated with an unexplained secondary hyperaldosteronism
[6]. JGCT may cause malignant hypertension [17]. A case
of JGCT associated with membranous glomerulonephritis
was also reported [18].
Radiological findings
Ultrasonography of the kidneys usually shows a hypoe-
choic mass [19,20]. Computed tomography (CT) scan is
very useful for the detection of renal tumor, even when
other imaging analyses is negative [8,21]. CT scan shows
f i n d i n go fl o w ,l o w - t oi s o -o rl o w -t oh i g h - d e n s i t yw i t h -
out enhancement [20,22-24]. In dynamic CT scan, JGCT
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during late phase after contrast enhancement [24-26].
Magnetic resonance imaging is also a powerful diagnostic
procedure [12,23,25]. MRI shows an iso-signal intensity
area on T1-weighted images and a high-signal intensity
area on T2-weighted images, but MRI findings seem to
variable [23,26,27].
Pathological findings
Macroscopic findings
Grossly, the tumor is well circumscribed and complete or
partial fibrous capsule is observed in most cases [9,28].
The cut surface of the tumor imparts yellow to gray-tan
in color with frequent hemorrhage [9]. The tumor is
usually small solitary and unilateral, but the tumors
exceeding 3 cm are occasionally observed [8,29,30]. A
case of extrarenal JGCT arising in bone has been
reported [31].
Microscopic findings
Histologically, the tumor consists of solid sheets of clo-
sedly packed uniform round to polygonal cells with oval
to round nuclei, pale to eosinophilic cytoplasm, incon-
spicuous nucleoli and indistinct cell border (Figure 1, 2)
[10]. Microcystic pattern is also seen [9,32,33]. Focal
moderate nuclear atypia may be seen, but mitotic figures
are generally absent [9]. Entrapped tubules are identified;
predominantly at the peripheral area of the tumor but
tubular cells suggestive of neoplastic nature has been
reported [28,29,34,35]. Thin-wall and thick-wall blood
vessels with hyalinization are intervened within the
tumor and antler vascular pattern simulating hemangio-
pericytoma may be noted [3,9,28,32,35]. Mast cells often
infiltrate in the stroma [4,36]. Penetration of fibrous cap-
sule or vascular invasion by tumor cells may be observed
in some cases [37-39] (Figure 3).
Histochemical findings
Intracytoplasmic granules suggestive of renin storage
m a yb ed e t e c t e db yB o w i e ,p e r i o d i ca c i d - A s c h i f f ,a n d
Figure 1 Microscopic findings. Low power view. Neoplastic cells
with ovoid to polygonal in shape proliferate with growth pattern of
solid sheets. Intervening tubular component is also seen.
Figure 2 Microscopic findings.H i g hp o w e rv i e w .C e l lb o r d e ri s
generally indistinct and mitotic activity is absent. There is no or
little pleomorphism of nuclei, but multinuclear cells are focally seen.
Figure 3 Microscopic findings. Vascular invasion is seen.
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29,40-42]. Toluidine blue stain is useful in the detection
of mast cells in the stroma [43].
Immunohistochemical findings
The diagnosis is confirmed by positivity for renin in the
cytoplasm [12,21,22,34,35,42]. However, renin positivity
may be observed in some cases of Wilms tumor, RCC or
renal oncocytoma [7]. Most neoplastic cells are diffusely
immunoreactive for vimentin and CD34 [44] (Figure 4).
The immunoreactivity to smooth muscle actin and
CD117 varies from case to case [9,10]. Tumor cells
demonstrate no reactivity to von Willebrand factor,
CD31, desmin, S-100 protein, melanosome-related anti-
gen, chromogranin A, synaptophysin, and neuron specific
enolase [9,35]. Epithelial components are positive for
cytokeratin CAM5.2 and cytokeratin 7 [35].
In situ hybridization findings
Messenger RNA of renin is found in the cytoplasm of
tumor cells of JGCT. Some investigators suggest that
renin synthesis and storage may be concordant [45],
whereas others consider that the positivity of messenger
RNA in the tumor cytoplasm may be due to uptake of
renin rather than renin production [37].
Ultrastructural findings
The cytoplasm of tumor cells contains characteristic
rhomboid-shaped renin protogranules, abundant rough
endoplasmic reticulum and prominent Golgi apparatus
[4,9,10,22,29,34,40-42,44,46]. Secretory granules of var-
ious size and shapes are also observed [36]. Micropino-
cytotic vesicles and submembranous plaques suggestive
of smooth muscle differentiation may be also contained
in the cytoplasm [32,47]. The presence of nerve fibers
have been reported [48]. Ultrastructural immunocyto-
chemistry showed that immunoreactive renin is
observed not only in crystalline protogranules or round
membrane bound granules but also in intermediate
form [49].
Differential Diagnosis
The distinction from glomus tumor, hemangiopericy-
toma, metanephric adenoma, papillary RCC, collecting
duct carcinoma (CDC), urothelial carcinoma (UC), renal
epithelioid angiomyolipoma (AML) and Wilms tumor
should be considered. JGCT may possess the growth pat-
tern reminiscent of glomus tumor. However, glomus
tumor contains no epithelial component and is immuno-
histochemically negative for renin. Hemangiopericytoma
lacks polygonal cells and thick-walled vessels. Solitary
fibrous tumor often shows the hemangiopericytomatous
pattern, but this tumor is frequently reactive for CD99
and bcl-2. JGCT with prominent papillary growth pattern
may resemble papillary RCC [35]. However, papillary
RCC lacks biphasic pattern of round to polygonal cells
and epithelial cells. Metanephric cells typically show aci-
nar growth pattern and psammoma bodies are often seen
in the stroma. Solid sheets growth pattern of JGCT may
evoke the diagnosis of CDC or poorly differentiated UC.
However, CDC or urothelial carcinoma is macroscopi-
cally located in the renal medulla or hilar region, respec-
tively, but the location of many JGCTs is the renal
cortex. Renal angiomyolipoma may contain minor adi-
pose tissue component and show the immunoreactivity
for melanosome-related antigen. Wilms’ tumor typically
contains blastemal cells showing nuclear overlapping.
Molecular genetic findings
There are only a few limited reports on genetic abnormal-
ities of JGCT. Using karyotype, comparative genomic
hybridization (CGH) and interphase fluorescence in situ
hybridization (FISH), the gain of chromosome 10 as well
as losses of chromosomes 9 and X and most of chromo-
some 11q may be important pathogenetic events in JGCT
[50]. One case demonstrated monosomy of chromosomes
X, 6, 9, 11, 15 and 21 using FISH analysis [51]. Two
tumors revealed losses of chromosomes 9 and 11 by CGH
[52]. Aneuploid karyotype and complex genomic imbal-
ance observed in two cases may reflect a possible develop-
ment for local recurrence or distant metastasis, namely
uncertain malignant potential [50,52].
Therapy
The complete tumor resection by radical or partial
nephrectomy is the best modality for JGCT [35,53]. Anti-
hypertensive agents should be treated for hypertension
until accurate diagnosis is made, but blood pressure,
Figure 4 Immunohistochemical findings. Tumor cells show the
labeling for CD34.
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omy in most cases with JGCT [2,23,25,54-56]. However,
hypertension may continue because of hypertensive
angiopathy even after the complete tumor removal in
approximately 10% of all cases [10,25,47].
Prognosis
The majority of cases with JGCT have behaved in a
benign manner and neither local recurrence nor metasta-
sis has occurred with either radical or partial nephrect-
omy. However, one metastatic case with JGCT has been
reported to date [38]. Additionally, a case of JGCT that
caused death due to massive brain hemorrhage secondary
to severe hypertension has been reported [57]. A case of
JGCT causing fetal demise has been noted [58].
Conclusion
Since the discovery of this tumor approximately 40 years
ago, many common histological features including histo-
chemistry, immunohistochemistry and ultrastructure have
been elucidated and, as a result, JGCT gained the status as
the distinct mesenchymal tumor entity from other renal
t u m o r .H o w e v e r ,t h e r ea r eo n l yaf e wg e n e t i cs t u d i e so f
JGCT because of the rarity of this disease. As we encoun-
tered a case of JGCT with vascular invasion, the true bio-
logical behavior of JGCT will be needed to be elucidated.
Accordingly, genetic features of JGCT need to be clarified
by the future investigations.
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